P A Marks - Publications, H-index & Citations

P A Marks

maastricht university

40H指数

86论文数

1.0W被引数

收录论文 13

发表时间

Packed for Ossification: High-Density Bioprinting of hPDC Spheroids in HAMA Toward Endochondral Ossification 为骨化而制备：通过高密度生物打印将hPDC微球体植入HAMA以实现软骨内骨化

Advanced Healthcare Materials

IF9.6

2026-03-15

OAAI

Ane Albillos Sanchez; Maria Paula Marks; Paula Casademunt; Adrián Seijas-Gamardo; Ioannis Papantoniou; Lorenzo Moroni; Carlos Mota

Histone Deacetylase Inhibitors: Potential in Cancer Therapy 组蛋白去乙酰化酶抑制剂: 在癌症治疗中的潜力

JOURNAL OF CELLULAR BIOCHEMISTRY

IF2.8

2009-05-20

684

OAAI

Marks, P. A.; Xu, W. -S.

Histone deacetylase inhibitors: molecular mechanisms of action 组蛋白去乙酰化酶抑制剂: 作用的分子机制

ONCOGENE

IF7.3

2007-08-13

1.4K

PREAI

Xu, W. S.; Parmigiani, R. B.; Marks, P. A.

Discovery and development of SAHA as an anticancer agent

ONCOGENE

IF7.3

2007-02-26

621

OAAI

Marks, P. A.

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2005-01-06

497

OAAI

Ungerstedt, JS; Sowa, Y; Xu, WS; Shao, Y; Dokmanovic, M; Perez, G; Ngo, L; Holmgren, A; Jiang, X; Marks, PA

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2004-01-20

583

OAAI

Gui, CY; Ngo, L; Xu, WS; Richon, VM; Marks, PA

Histone deacetylases

CURRENT OPINION IN PHARMACOLOGY

IF4.2

2003-08-01

400

PREAI

Marks, PA; Miller, T; Richon, VM

Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2000-08-02

1.2K

PREAI

Marks, PA; Richon, VM; Rifkind, RA

Health care reform: Has it really begun?

ACADEMIC MEDICINE

IF5.2

1999-03-01

OAAI

Marks, PA

Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates BCL-2 expression in human myeloma cells

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

1998-01-06

OAAI

Siegel, DS; Zhang, X; Feinman, R; Teitz, T; Zelenetz, A; Richon, VM; Rifkind, RA; Marks, PA; Michaeli, J

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

1996-06-11

466

OAAI

Richon, VM; Webb, Y; Merger, R; Sheppard, T; Jursic, B; Ngo, L; Civoli, F; Breslow, R; Rifkind, RA; Marks, PA

ERYTHROLEUKEMIC DIFFERENTIATION

ANNUAL REVIEW OF BIOCHEMISTRY

IF20.5

1978-06-01

874

PREAI

MARKS, PA; RIFKIND, RA

PERICARDIAL EFFUSION ASSOCIATED WITH MYXEDEMA

ANNALS OF INTERNAL MEDICINE

IF15.2

1953-08-01

PREAI

MARKS, PA; ROOF, BS

研究方向